Exosens stock analysis
Want to see FR:EXENS full AI Analyst Report?
Exosens (EXENS) Stock Price & Analysis
EXENS Stock Chart & Stats
- Day’s Range
- EUR 50.50 - EUR 51.60
- 52-Week Range
- EUR 40.00 - EUR 74.00
- Previous Close
- EUR 52.30
- Volume
- N/A
- Average Volume (3M)
- 83.04K
- Market Cap
- EUR 2.59B
- Enterprise Value
- EUR 3.08B
- Total Cash (Recent Filing)
- EUR 105.20M
- Total Debt (Recent Filing)
- EUR 269.50M
- Price to Earnings (P/E)
- 86.3
- Beta
- 0.63
- Next Earnings
- Feb 22, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 27, 2026
- Dividend Yield
- 0.59%
Bulls Say, Bears Say
Bulls Say
Consistent Revenue Growth
Sustained revenue growth across multiple years indicates expanding demand for Exosens’ optoelectronic and imaging offerings. Continued top-line progress supports investment in product development, strengthens customer relationships, and provides a durable foundation for future earnings growth.
Improved Profitability
The transition from earlier losses to sustained profitability demonstrates meaningful operating improvement and a stronger earnings model. EBITDA margins near 30% in recent years suggest that Exosens has built substantial operating profitability that can support reinvestment and financial resilience.
Material Deleveraging
Substantial deleveraging has improved Exosens’ balance-sheet flexibility and reduced the financial burden inherited from earlier years. A larger equity base relative to debt should provide greater capacity to absorb business variability, fund strategic initiatives, and maintain operations through procurement cycles.
Bears Say
Gross-Margin Compression
The steep gross-margin decline raises concerns about the durability of Exosens’ recent profitability, whether caused by product mix, pricing pressure, or cost inflation. If the weaker margin persists, it could reduce earnings leverage, limit reinvestment capacity, and weaken the benefit of continued revenue growth.
Volatile Free-Cash-Flow Conversion
Positive cash generation is offset by inconsistent conversion from earnings into free cash flow. The 2025 deterioration suggests that reinvestment or working-capital demands can materially affect cash availability, making funding capacity less predictable even when reported profitability remains positive.
Residual Debt Burden
Although leverage has improved substantially, Exosens still carries meaningful absolute debt and a recent history of materially higher leverage. This leaves some exposure to balance-sheet pressure if earnings or cash conversion weaken, while moderate 2025 return on equity of about 9.6% limits the offsetting benefit.
Exosens News
EXENS FAQ
What was Exosens’s price range in the past 12 months?
What is Exosens’s market cap?
When is Exosens’s upcoming earnings report date?
How were Exosens’s earnings last quarter?
Is Exosens overvalued?
Does Exosens pay dividends?
What is Exosens’s EPS estimate?
How many shares outstanding does Exosens have?
What happened to Exosens’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Exosens?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Exosens
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.
- Sector
- Industrials
- Industry
- Aerospace & Defense
- CEO
- Jerome Cerisier
- Employees
- 2,000
- Website
- www.exosens.com
- Address
- Building 5, Mérignac, NA, 33700, FR
Exosens (EXENS) Earnings & Revenues
EXENS Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |











